Published in Transplantation on May 01, 1983
18F-4V for PET-CT imaging of VCAM-1 expression in atherosclerosis. JACC Cardiovasc Imaging (2009) 2.17
Myeloperoxidase-rich Ly-6C+ myeloid cells infiltrate allografts and contribute to an imaging signature of organ rejection in mice. J Clin Invest (2010) 1.48
Inflammatory cells in transplanted kidneys are infected by human cytomegalovirus. Am J Pathol (1988) 1.41
Monocyte infiltration and kidney allograft dysfunction during acute rejection. Am J Transplant (2008) 1.15
The innate immune system in allograft rejection and tolerance. J Immunol (2007) 1.13
T lymphocyte cloning from rejected human kidney allografts. Growth frequency and functional/phenotypic analysis. J Clin Invest (1986) 0.98
Blockade of p-selectin is sufficient to reduce MHC I antibody-elicited monocyte recruitment in vitro and in vivo. Am J Transplant (2012) 0.98
Macrophages: contributors to allograft dysfunction, repair, or innocent bystanders? Curr Opin Organ Transplant (2012) 0.96
Deficiency of C5aR prolongs renal allograft survival. J Am Soc Nephrol (2010) 0.88
An experimental model of acute humoral rejection of renal allografts associated with concomitant cellular rejection. Am J Pathol (2008) 0.87
Nanoparticle PET-CT detects rejection and immunomodulation in cardiac allografts. Circ Cardiovasc Imaging (2013) 0.84
The divergent roles of macrophages in solid organ transplantation. Curr Opin Organ Transplant (2015) 0.81
A shift towards pro-inflammatory CD16+ monocyte subsets with preserved cytokine production potential after kidney transplantation. PLoS One (2013) 0.80
A Small Molecule β2 Integrin Agonist Improves Chronic Kidney Allograft Survival by Reducing Leukocyte Recruitment and Accompanying Vasculopathy. Front Med (Lausanne) (2014) 0.79
Effector mechanisms of rejection. Cold Spring Harb Perspect Med (2013) 0.79
Mononuclear phagocytes: a major population of effector cells responsible for rejection of allografted tumor cells in mice. Proc Natl Acad Sci U S A (1991) 0.78
Relationships among injury, fibrosis, and time in human kidney transplants. JCI Insight (2016) 0.78
Infiltration of Macrophages Correlates with Severity of Allograft Rejection and Outcome in Human Kidney Transplantation. PLoS One (2016) 0.76
Retrospective study of histological features of acute rejection in renal allografts and comparison with circulating T cell populations. J Clin Pathol (1985) 0.75
Histopathological diagnosis of acute and chronic rejection in pediatric kidney transplantation. Pediatr Nephrol (2013) 0.75
Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med (2001) 17.24
Fibrinogen stimulates macrophage chemokine secretion through toll-like receptor 4. J Immunol (2001) 3.76
Transforming growth factor-beta regulates tubular epithelial-myofibroblast transdifferentiation in vitro. Kidney Int (1999) 3.09
CCR5(+) and CXCR3(+) T cells are increased in multiple sclerosis and their ligands MIP-1alpha and IP-10 are expressed in demyelinating brain lesions. Proc Natl Acad Sci U S A (1999) 3.07
Early cellular events in a systemic graft-vs.-host reaction. II. Autoradiographic estimates of the frequency of donor lymphocytes which respond to each Ag-B-determined antigenic complex. J Exp Med (1975) 2.78
Requirement for T-cell apoptosis in the induction of peripheral transplantation tolerance. Nat Med (1999) 2.74
A novel, simple, reliable, and sensitive method for multiple immunoenzyme staining: use of microwave oven heating to block antibody crossreactivity and retrieve antigens. J Histochem Cytochem (1995) 2.71
The specific selection of recirculating lymphocytes by antigen in normal and preimmunized rats. J Exp Med (1972) 2.66
Specific unresponsiveness of recirculating lymphocytes ater exposure to histocompatibility antigen in F 1 hybrid rats. Nat New Biol (1971) 2.50
CD28-B7 blockade after alloantigenic challenge in vivo inhibits Th1 cytokines but spares Th2. J Exp Med (1995) 2.48
Barriers to xenotransplantation. Nat Med (1995) 2.44
Tubular epithelial-myofibroblast transdifferentiation in progressive tubulointerstitial fibrosis in 5/6 nephrectomized rats. Kidney Int (1998) 2.35
Nasal administration of amyloid-beta peptide decreases cerebral amyloid burden in a mouse model of Alzheimer's disease. Ann Neurol (2000) 2.30
Monocyte chemoattractant protein-1 promotes the development of diabetic renal injury in streptozotocin-treated mice. Kidney Int (2006) 2.22
Advanced glycation end products cause epithelial-myofibroblast transdifferentiation via the receptor for advanced glycation end products (RAGE). J Clin Invest (2001) 2.20
Importance of ICOS-B7RP-1 costimulation in acute and chronic allograft rejection. Nat Immunol (2001) 2.10
A targeted point mutation in thrombomodulin generates viable mice with a prethrombotic state. J Clin Invest (1998) 2.08
Tissue culture of isolated glomeruli in experimental crescentic glomerulonephritis. J Exp Med (1978) 2.02
Migration inhibitory factor expression in experimentally induced endotoxemia. Am J Pathol (1997) 2.00
The macrophagen in human rapidly progressive glomerulonephritis. Lancet (1976) 1.88
The pathogenic role of macrophage migration inhibitory factor in immunologically induced kidney disease in the rat. J Exp Med (1997) 1.86
Lack of chemokine receptor CCR1 enhances Th1 responses and glomerular injury during nephrotoxic nephritis. J Clin Invest (1999) 1.84
Glomerulonephritis. Lancet (2005) 1.81
The role of polymorphonuclear leucocytes in the autologous phase of nephrotoxic nephritis. Clin Exp Immunol (1975) 1.75
PDGF signal transduction inhibition ameliorates experimental mesangial proliferative glomerulonephritis. Kidney Int (2001) 1.69
Activation of coagulation and angiogenesis in cancer: immunohistochemical localization in situ of clotting proteins and vascular endothelial growth factor in human cancer. Am J Pathol (1998) 1.65
Loss of ATP diphosphohydrolase activity with endothelial cell activation. J Exp Med (1997) 1.62
A quantitative evaluation of anticoagulants in experimental nephrotoxic nephritis. Clin Exp Immunol (1975) 1.61
The cDNA cloning and characterization of inositol polyphosphate 4-phosphatase type II. Evidence for conserved alternative splicing in the 4-phosphatase family. J Biol Chem (1997) 1.60
Tubules are the major site of M-CSF production in experimental kidney disease: correlation with local macrophage proliferation. Kidney Int (2001) 1.60
Leukocyte analysis using monoclonal antibodies in human glomerulonephritis. Kidney Int (1987) 1.60
Early cellular events in a systemic graft-vs.-host reaction. I. The migration of responding and nonresponding donor lymphocytes. J Exp Med (1975) 1.57
Interleukin-1 induces tubular epithelial-myofibroblast transdifferentiation through a transforming growth factor-beta1-dependent mechanism in vitro. Am J Kidney Dis (2001) 1.56
The role of C3 in the autologous phase of nephrotoxic nephritis. Clin Exp Immunol (1976) 1.51
Blockade of T-cell costimulation prevents development of experimental chronic renal allograft rejection. Proc Natl Acad Sci U S A (1996) 1.51
Defective cytostatic activity of pulmonary alveolar macrophages in primary lung cancer. Chest (1990) 1.49
Antigenic heterogeneity of human mononuclear phagocytes: immunohistologic analysis using monoclonal antibodies. Blood (1983) 1.48
Plasma cytokines and chemokines in primary graft dysfunction post-lung transplantation. Am J Transplant (2008) 1.47
Prolonged discordant xenograft survival and delayed xenograft rejection in a pig-to-baboon orthotopic cardiac xenograft model. J Thorac Cardiovasc Surg (1998) 1.46
Targeting of the chemokine receptor CCR1 suppresses development of acute and chronic cardiac allograft rejection. J Clin Invest (2000) 1.44
Transforming growth factor-beta1 and tumor growth factor-beta-inducible gene-H3 in nonrenal transplant cyclosporine nephropathy. Transplantation (2001) 1.43
Differential effects of cyclosporine A, methylprednisolone, mycophenolate, and rapamycin on CD154 induction and requirement for NFkappaB: implications for tolerance induction. Transplantation (2000) 1.43
Expression of the chemokine receptor CXCR3 and its ligand IP-10 during human cardiac allograft rejection. Circulation (2001) 1.42
Proteinuria and the expression of the podocyte slit diaphragm protein, nephrin, in diabetic nephropathy: effects of angiotensin converting enzyme inhibition. Diabetologia (2002) 1.40
De Novo renal expression of macrophage migration inhibitory factor during the development of rat crescentic glomerulonephritis. Am J Pathol (1996) 1.40
The NOD Idd9 genetic interval influences the pathogenicity of insulitis and contains molecular variants of Cd30, Tnfr2, and Cd137. Immunity (2000) 1.40
Selective inhibitory effects of the anticoagulant activated protein C on the responses of human mononuclear phagocytes to LPS, IFN-gamma, or phorbol ester. J Immunol (1994) 1.40
Renal protection by angiotensin II receptor antagonists in patients with type 2 diabetes. Med J Aust (2001) 1.39
Serum alpha 2-macroglobulin in haemodialysis patients: baseline and kinetic studies. Nephrol Dial Transplant (1993) 1.39
Immunofluorescent studies in renal biopsies in pre-eclampsia. Br Med J (1974) 1.38
Australians with renal disease: a new national survey. Med J Aust (1999) 1.38
The role of macrophages in glomerulonephritis. Nephrol Dial Transplant (2001) 1.38
Accommodation of vascularized xenografts: expression of "protective genes" by donor endothelial cells in a host Th2 cytokine environment. Nat Med (1997) 1.38
Initiation and evolution of interstitial leukocytic infiltration in experimental glomerulonephritis. Kidney Int (1991) 1.35
Expression of VCAM-1 and E-selectin in an in vivo model of endothelial activation. Am J Pathol (1993) 1.35
Tubular phenotypic change in progressive tubulointerstitial fibrosis in human glomerulonephritis. Am J Kidney Dis (2001) 1.34
Detection of lymphokines and lymphokine receptors in pulmonary sarcoidosis. Immunohistologic evidence that inflammatory macrophages express IL-2 receptors. Am J Pathol (1986) 1.33
Leukocyte recruitment during onset of experimental allergic encephalomyelitis is CCR1 dependent. Eur J Immunol (2000) 1.33
Targeted deletion of CX(3)CR1 reveals a role for fractalkine in cardiac allograft rejection. J Clin Invest (2001) 1.31
The macrophage in the development of experimental crescentic glomerulonephritis. Studies using tissue culture and electron microscopy. Am J Pathol (1979) 1.31
Protective genes expressed in endothelial cells: a regulatory response to injury. Immunol Today (1997) 1.31
The incidence of biopsy-proven glomerulonephritis in Australia. Nephrol Dial Transplant (2001) 1.30
Production of tumor necrosis factor and interleukin-1 by macrophages from human atheromatous plaques. Am J Pathol (1993) 1.30
The effect of defibrination on macrophage participation in rabbit nephrotoxic nephritis: studies using glomerular culture and electronmicroscopy. Clin Exp Immunol (1979) 1.28
Local macrophage proliferation in human glomerulonephritis. Kidney Int (1998) 1.26
Upregulation of cytokines associated with macrophage activation in the Lewis-to-F344 rat transplantation model of chronic cardiac rejection. Transplantation (1995) 1.25
CD28-B7 costimulatory blockade by CTLA4Ig prevents actively induced experimental autoimmune encephalomyelitis and inhibits Th1 but spares Th2 cytokines in the central nervous system. J Immunol (1995) 1.25
Chronic cardiac rejection in the LEW to F344 rat model. Blockade of CD28-B7 costimulation by CTLA4Ig modulates T cell and macrophage activation and attenuates arteriosclerosis. J Clin Invest (1996) 1.24
Delayed xenograft rejection. Immunol Today (1996) 1.23
Defibrination with ancrod in nephrotoxic nephritis in rabbits. Kidney Int (1976) 1.23
Suppression of experimental crescentic glomerulonephritis by the interleukin-1 receptor antagonist. Kidney Int (1993) 1.22
Effects of explosive brain death on cytokine activation of peripheral organs in the rat. Transplantation (1998) 1.22
Beneficial effects of targeting CCR5 in allograft recipients. Transplantation (2001) 1.22
Brain death and its influence on donor organ quality and outcome after transplantation. Transplantation (1999) 1.22
Expression of macrophage migration inhibitory factor in human glomerulonephritis. Kidney Int (2000) 1.20
Increased expression of IL-4 and IL-10 and decreased expression of IL-2 and interferon-gamma in long-surviving mouse heart allografts after brief CD4-monoclonal antibody therapy. Transplantation (1995) 1.17
Nasal A beta treatment induces anti-A beta antibody production and decreases cerebral amyloid burden in PD-APP mice. Ann N Y Acad Sci (2000) 1.17
Membrane antigens of human cells of the monocyte/macrophage lineage studied with monoclonal antibodies. Pathology (1983) 1.17
Immunohistological studies with monoclonal antibodies. Methods Enzymol (1986) 1.16
Immunohistological analysis of serial biopsies taken during human renal allograft rejection. Changing profile of infiltrating cells and activation of the coagulation system. Transplantation (1985) 1.16
Monoclonal antibodies to identify tumour cells in CSF. Lancet (1983) 1.15
A comparison of fixatives and immunohistochemical technics for use with monoclonal antibodies to cell surface antigens. Am J Clin Pathol (1982) 1.15
Tissue culture of isolated human glomeruli. Pathology (1978) 1.15
P-selectin and platelet-activating factor mediate initial endotoxin-induced neutropenia. J Exp Med (1994) 1.14
Identification of a major sialoprotein in the glycocalyx of human visceral glomerular epithelial cells. J Clin Invest (1986) 1.13
Identification of IL 2R+ T cells and macrophages within rejecting rat cardiac allografts, and comparison of the effects of treatment with anti-IL 2R monoclonal antibody or cyclosporin. J Immunol (1987) 1.13
Membranous nephropathy and thromboembolism: is prophylactic anticoagulation warranted? Nephron (1993) 1.12
Analysis of intragraft effector mechanisms associated with human renal allograft rejection: immunohistological studies with monoclonal antibodies. Immunol Rev (1984) 1.12